A patient who died when a Zoll LifeVest failed to work has led the manufacturer Zoll Medical and the FDA to issue a safety alert for physicians and patients using the wearable heart monitor and ...

CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL Medical Corporation (NASDAQ GS: ZOLL), a manufacturer of medical devices and related software solutions, announced that a study demonstrating a reduction in ...

Zoll Medical Corporation, which received FDA clearance a few years ago for both home and hospital versions of its wearable defibrillator LifeVest, is now dealing with a range of lawsuits and FDA ...

CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL Medical Corporation (NasdaqGS: ZOLL), a manufacturer of medical devices and related software solutions, announced today that more than 30,000 patients at high ...

A phase 3 trial of Zoll Medical’s LifeVest has missed its primary endpoint. The study found that people who started using the wearable defibrillator the week after they had a heart attack were as ...

CHELMSFORD, Mass.--(BUSINESS WIRE)-- ZOLL Medical Corporation (NASDAQ GS: ZOLL), a manufacturer of medical devices and related software solutions, announced today that physicians at all of the 14 ...

CHELMSFORD, Mass., March 10, 2018 /PRNewswire/ -- ZOLL ® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, announced today the results ...

ESC Heart Failure Late Breaker: Largest single LifeVest® WCD study of NICM and MI/CAD patients shows high appropriate treatment rates during early period of contemporary GDMT CHELMSFORD, ...

Zoll Medical Corp. said its wearable resuscitation device LifeVest faces the possibility of reduced reimbursement rates. In a filing Monday with the Securities and Exchange Commission, Zoll said a ...

ESC Heart Failure Late Breaker: Largest single LifeVest® WCD study of NICM and MI/CAD patients shows high appropriate treatment rates during early period of contemporary GDMT ZOLL®, an Asahi Kasei ...